Literature DB >> 31629770

The Molecular Basis of MeCP2 Function in the Brain.

Rebekah Tillotson1, Adrian Bird2.   

Abstract

MeCP2 is a reader of the DNA methylome that occupies a large proportion of the genome due to its high abundance and the frequency of its target sites. It has been the subject of extensive study because of its link with 'MECP2-related disorders', of which Rett syndrome is the most prevalent. This review integrates evidence from patient mutation data with results of experimental studies using mouse models, cell lines and in vitro systems to critically evaluate our understanding of MeCP2 protein function. Recent evidence challenges the idea that MeCP2 is a multifunctional hub that integrates diverse processes to underpin neuronal function, suggesting instead that its primary role is to recruit the NCoR1/2 co-repressor complex to methylated sites in the genome, leading to dampening of gene expression.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  DNA methylation; MeCP2; Neurological function; Rett syndrome; Transcriptional regulation

Year:  2019        PMID: 31629770     DOI: 10.1016/j.jmb.2019.10.004

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  29 in total

1.  The Pathophysiology of Rett Syndrome With a Focus on Breathing Dysfunctions.

Authors:  Jan-Marino Ramirez; Marlusa Karlen-Amarante; Jia-Der Ju Wang; Nicholas E Bush; Michael S Carroll; Debra E Weese-Mayer; Alyssa Huff
Journal:  Physiology (Bethesda)       Date:  2020-11-01

Review 2.  Emerging Insights into the Distinctive Neuronal Methylome.

Authors:  Adam W Clemens; Harrison W Gabel
Journal:  Trends Genet       Date:  2020-08-21       Impact factor: 11.639

3.  Targeted RNA editing in brainstem alleviates respiratory dysfunction in a mouse model of Rett syndrome.

Authors:  John R Sinnamon; Michael E Jacobson; John F Yung; Jenna R Fisk; Sophia Jeng; Shannon K McWeeney; Lindsay K Parmelee; Chi Ngai Chan; Siu-Pok Yee; Gail Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-08       Impact factor: 12.779

4.  Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin.

Authors:  Liang Wang; Mingli Hu; Mei-Qing Zuo; Jicheng Zhao; Di Wu; Li Huang; Yongxin Wen; Yunfan Li; Ping Chen; Xinhua Bao; Meng-Qiu Dong; Guohong Li; Pilong Li
Journal:  Cell Res       Date:  2020-02-28       Impact factor: 25.617

Review 5.  The Emerging Roles of Heterochromatin in Cell Migration.

Authors:  Gabi Gerlitz
Journal:  Front Cell Dev Biol       Date:  2020-05-27

6.  Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2.

Authors:  David Ortega-Alarcon; Rafael Claveria-Gimeno; Sonia Vega; Olga C Jorge-Torres; Manel Esteller; Olga Abian; Adrian Velazquez-Campoy
Journal:  Biomolecules       Date:  2020-11-10

7.  Quantitative analysis questions the role of MeCP2 as a global regulator of alternative splicing.

Authors:  Kashyap Chhatbar; Justyna Cholewa-Waclaw; Ruth Shah; Adrian Bird; Guido Sanguinetti
Journal:  PLoS Genet       Date:  2020-10-13       Impact factor: 5.917

Review 8.  Proteomic and transcriptional changes associated with MeCP2 dysfunction reveal nodes for therapeutic intervention in Rett syndrome.

Authors:  Ketan Marballi; Jessica L MacDonald
Journal:  Neurochem Int       Date:  2021-05-26       Impact factor: 4.297

Review 9.  MeCP2 and Chromatin Compartmentalization.

Authors:  Annika Schmidt; Hui Zhang; M Cristina Cardoso
Journal:  Cells       Date:  2020-04-03       Impact factor: 6.600

10.  The Expanding Therapeutic Potential of Neuronal KCC2.

Authors:  Bor Luen Tang
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.